Growth stimulation and epidermal growth factor receptor induction in cyclooxygenase-overexpressing human colon carcinoma cells

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 403-407

  Yoshimoto, Tanihiro ^a   Takahashi, Yoshitaka ^a   Kinoshita, Takahiro ^a   Sakashita, Toshiki ^a   Inoue, Hiroyasu ^b   Tanabe, Tadashi ^b  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; ISOENZYME; MEMBRANE PROTEIN; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CARCINOMA CELL; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; COLON CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; GROWTH STIMULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; KINETICS; METABOLISM; PHYSIOLOGY;

EUKARYOTA; VECTORS;

CELL DIVISION; COLONIC NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; KINETICS; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0038107213     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_62     Document Type: Conference Paper

References (17)

1. R.N. Dubois, S.B. Abramson, L. Crofford, R.A. Gupta, L.S. Simon, L.B.A. Van De Putte and P.E. Lipsky, Cyclooxygenase in biology and disease, FASEB J. 12: 1063 (1998).
2. W.L. Smith, R.M. Garavito, and D.L. DeWitt, Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2, J. Biol. Chem. 271: 33157 (1996).
3. J.R. Vane, Y.S. Bakhle, and R.M. Botting, Cyclooxygenase 1 and 2, Annu. Rev. Pharmacol Toxicol. 38: 97 (1998).
4. S. Mizushima and S. Nagata, pEF-BOS, a powerful mammalian expression vector, Nucleic Acids Res. 18: 5322 (1990).
5. D. Hwang, D. Scollard, J. Byrne, and E. Levine, Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer, J. Natl. Cancer Inst. 90: 455 (1998).
6. M. Dore, L.C. Cote, A. Mitchell, and J. Sirois, Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas, J. Histochem. Cytochem. 46: 77 (1998).
7. C.E. Eberhart, R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois, Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology 107: 1183 (1994).
8. H. Sano, Y. Kawahito, R.L. Wilder, A. Hashiramoto, S. Mukai, K. Asai, S. Kimura, H. Kato, M. Kondo, and T. Hla, Expression of cyclooxygenase-1 and -2 in human colorectal cancer, Cancer Res. 55: 3785 (1995).
9. S.L. Kargman, G.P. O'Neill, P.J. Vickers, J.F. Evans, J.A. Mancini, and S. Jothy, Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer, Cancer Res. 55: 2556 (1995).
10. 2 of rabbit polymorphonuclear leukocytes, Proc. Natl. Acad. Sci. USA 75: 2955 (1978).
11. J.M. Lehmann, J.M. Lenhard, B.B. Oliver, G.M. Ringold, and S.A. Kliewer, Peroxisome proliferator-activated receptors a and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs, J. Biol. Chem. 272: 3406 (1997).
12. G. Carpenter, and S. Cohen, Epidermal growth factor, J. Biol. Chem. 265: 7709 (1990).
13. M. Bos, J. Mendelsohn, Y-H. Kim, J. Albanell, D.W. Fry, and J. Baselga, PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner, Clin. Cancer Res. 3: 2099 (1997).
14. J.D. Moyer, E.G. Barbacci, K.K. Iwata, L. Arnold, B. Boman, A. Cunningham, C. DiOrio, J. Doty, M.J. Morin, M.P. Moyer, M. Neveu, V.A. Pollack, L.R. Pustilnik, M.M. Reynolds, D. Sloan, A. Theleman, and P. Miller, Induction of apotosis and cell cycle arrest by CP-358, 774, an inhibitor of epidermal growth factor receptor tyrosine kinase, Cancer Res. 57: 4838 (1997).
15. X. Wu, Z. Fan, H. Masui, N. Rosen, and J. Mendelsohn, Apotosis induced by an anti-epidermal growth factor receptor monoclonal antibody in human colorectal carcinoma cell line and its delay by insulin, J. Clin. Invest. 95: 1897 (1995).
16. S.D. Markowitz, K. Molkentin, C. Gerbic, J. Jackson, T. Stellato, and J.K.V. Willson, Growth stimulation by coexpression of transforming growth factor-a and epidermal growth factor-receptor in normal and adenomatous human colon epithelium, J. Clin. Invest. 86: 356 (1990).
17. R.J. Coffey, C.J. Hawkey, L. Damstrup, R. Graves-Deal, V.C. Daniel, P.J. Dempsey, R. Chinery, S.C. Kirkland, R.N. DuBois, T.J. Jetton, and J.D. Morrow, Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells, Proc. Natl. Acad. Sci. USA 94: 657 (1997).